Switch to:
AbbVie Inc  (NYSE:ABBV) Net Issuance of Debt: $634 Mil (TTM As of Sep. 2017)

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. AbbVie Inc's net issuance of debt for the three months ended in Sep. 2017 was $395 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Sep. 2017 was $634 Mil.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

AbbVie Inc Annual Data

Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Net Issuance of Debt Premium Member Only Premium Member Only Premium Member Only 15,586.00 -601.00 -5.00 16,623.00 5,588.00

AbbVie Inc Quarterly Data

Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Net Issuance of Debt Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -495.00 229.00 17.00 -7.00 395.00

Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2017 was 229 (Dec. 2016 ) + 17 (Mar. 2017 ) + -7 (Jun. 2017 ) + 395 (Sep. 2017 ) = $634 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Related Terms


Headlines

From the Internet

Gilead Buying New Growth

- Seekingalpha 2017-11-22 09:56:13

Trading Quality Stocks Short Term Rates Higher Update

- Seekingalpha 2017-11-22 07:44:46

Dividend Aristocrats Focus Part 45 Abbvie

- Seekingalpha 2017-11-21 21:40:19

New Div Block Quarterly Earnings Round Ii Part 2

- Seekingalpha 2017-11-21 10:07:03

Ultragenyx Reaches Finish Line Rare Disease

- Seekingalpha 2017-11-21 02:45:49

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK